Karen's Fight for Accountability
Simply because Karen’s prescription was filled with a generic drug, not a brand, her legal rights are now in doubt.
Karen, of Plaistow, N.H., was prescribed a drug for shoulder pain and it was filled with generic sulindac. Soon after, two-thirds of Karen’s skin began shedding off. She spent months in a burn unit in a medically induced coma, covered in gauze. Karen endured 13 eye surgeries and numerous cornea implants. She now has trouble walking, is legally blind and will need care for the rest of her life.
The condition is called Stevens-Johnson syndrome (SJS) and it was a direct result of taking the generic drug. Karen's legal team argues that the drug’s design was dangerous and defective. Three lower courts concurred, awarding Karen damages for her injuries.
The U.S. Supreme Court will hear Karen's case, Mutual Pharmaceutical v. Bartlett, about the legal responsibility generic manufacturer’s have for the safety of their drugs. Will the Supreme Court rob patients of their rights, by ruling against accountability for defective drugs?